Echinacea purpurea has been widely used for the prevention and treatment of upper respiratory tract infections and the common cold. The restraint stress has been reported to suppress a broad spectrum of immune functions. The aim of this study was to investigate the protective effects of the pressed juice of E. purpurea (L.) Moench (EFLA®894; Echinacea) against restraint stress-induced immunosuppression in BALB/c mice. Echinacea significantly normalized the restraint stress-induced reduction in splenocyte proliferation and splenic natural killer (NK) cell activity (P < .05). Echinacea treatment significantly increased the percentages of CD4+ and CD8+ T lymphocytes in the blood (P < .05). In addition, Echinacea restored serum cytokine levels, including interleukin-6 (IL-6), interleukin-10 (IL-10), and interleukin-17 (IL-17), as well as the mRNA expressions of these cytokines in spleen (P < .05). Our findings suggest that Echinacea might have beneficial effects on restraint stress-induced immunosuppression by increasing splenocyte proliferation and NK cell activity, while modulating T lymphocyte subsets and cytokine levels in the blood.
Get full access to this article
View all access options for this article.
References
1.
McEwenBS: Protective and damaging effects of stress mediators. N Engl J Med, 1998; 338:171–179.
2.
KourK, BanS: Augmentation of immune response by chicoric acid through the modulation of CD28/CTLA-4 and Th1 pathway in chronically stressed mice. Neuropharmacology, 2011; 60:852–860.
3.
IwakabeK, ShimadaM, OhtaA, et al.: The restraint stress drives a shift in Th1/Th2 balance toward Th2-dominant immunity in mice. Immunol Let, 1998; 62:39–43.
4.
LépineJP, BrileyM: The increasing burden of depression. Neuropsychiatr Dis Treat, 2011; 7:3–7.
5.
KuriharaH, KodaH, AsamiS, KisoY, TanakaT: Contribution of the antioxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with restraint stress. Life Sci, 2002; 70:2509–2520.
6.
HeRR, YaoXS, LiHY, et al.: The anti-stress effects of Sarcandra glabra extract on restraint-evoked immunocompromised. Biol Pharm Bull, 2009; 32:247–252.
7.
HimmerichH, FischerJ, BauerK, et al.: Stress-induced cytokine changes in rats. Eur Cytokine Netw, 2013; 24:97–103.
KourK, PandeyA, SuriKA, et al.: Restoration of stress-induced altered T cell function and corresponding cytokines patterns by Withanolide A. Int Immunopharmacol, 2009; 9:1137–1144.
10.
CraigWJ: Health-promoting properties of common herbs. Am J Clin Nutr, 1999; 70:491S–499S.
11.
KumarKM, RamaiahS: Pharmacological importance of Echinacea purpurea. Int J Pharma Bio Sci, 2011; 2:304–314.
12.
BlumenthalM, GoldbergA, BrinckmannJ: Echinacea purpurea Herb. In: Herbal Medicine: Expanded Commission E Monographs (BlumenthalM, GoldbergA, BrinckmannJ, eds.). Integrative Medicine Communications, Inc., Newton, MA, 2000, pp. 96–97.
13.
WoelkartK, LindeK, BarrettB: Echinacea for preventing and treating the common cold. Planta Med, 2008; 74:633–637.
14.
YamadaK, HungP, ParkTK, ParkPJ, LimBO: A comparison of the immunostimulatory effects of the medicinal herbs Echinacea, Ashwagandha and Brahmi. J Ethnopharmaco, 2011; 137:231–235.
15.
BauerR, WagnerH: Echinacea species as potential immunostimulatory drugs. In: Economic and Medicinal Plant Research (WagnerH, FarnsworthNR, eds.). Academic Press, New York, NY, 1991, pp. 253–321.
16.
SeeDM, BroumandN, SahlL, TillesJG: In vitro effects of Echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology, 1997; 35:229–235.
17.
BurgerRA, TorresAR, WarrenRP, CaldwellVD, HughesBG: Echinacea-induced cytokine production by human macrophages. Int J Immunopharmacol, 1997; 19:371–379.
18.
FujiiF, HashimotoT, VerbruggenM, et al.: The immunostimulating effect by ingestion of an Echinacea purpurea preparation. Pharmacometrics, 2011; 80:79–88.
19.
LivakKJ, SchmittgentTD: Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods, 2001; 25:402–408.
20.
MishimaS, SaitoK, MaruyamaH, et al.: Antioxidant and immuno-enhancing effects of Echinacea purpurea. Biol Pharm Bull, 2004; 27:1004–1009.
21.
ZhaiZ, LiuY, WuL, et al.: Enhancement of innate and adaptive immune functions by multiple Echinacea species. J Med Food, 2007; 10:423–434.
22.
RodríguezRM, López-VázquezA, López-LarreaC: Immune systems evolution. In: Sensing in Nature (RodríguezRM, ed.). Landes Bioscience and Springer Science+Business Media LLC, New York, NY, 2012, pp. 237–251.
23.
AramaC, Assefaw-ReddaY, RodriguezA, et al.: Heterologous prime-boost regimen adenovector 35-circumsporozoite protein vaccine/recombinant Bacillus Calmette-Guerin expressing the Plasmodium falciparum circumsporozoite induces enhanced long-term memory immunity in BALB/c mice. Vaccine, 2012; 30:4040–4045.
24.
MontomoliE, PiccirellaS, KhadangB, et al.: Current adjuvants and new perspectives in vaccine formulation. Expert Rev Vaccines, 2011; 10:1053–1061.
25.
GillHS, RutherfurdKJ, PrasadJ, GopalPK: Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br J Nutr, 2000; 83:167–176.
26.
WhitesideTL, HerbermanRB: The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol, 1995; 7:704–710.
27.
BironCA, NguyenKB, PienGC, CousensLP, Salazar-MatherTP: Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol, 1999; 17:189–220.
28.
ChauhanPS, SattiNK, SuriKA, AminaM, BaniS: Stimulatory effects of Cuminum cyminum and flavonoid glycoside on Cyclosporine-A and restraint stress induced immune-suppression in Swiss albino mice. Chem Biol Interact, 2010; 185:66–72.
29.
LiuC, WalterTS, HuangP, et al.: Structural and functional insights of RANKL–RANK interaction and signalling. J Immunol, 2010; 184:6910–6919.
30.
RaggattLJ, PartridgeNC: Cellular and molecular mechanisms of bone remodelling. J Biol Chem, 2010; 285:25103–25108.
31.
LiY, ToraldoG, LiA, et al.: B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood, 2007; 109:3839–3848.
32.
Kiecolt-GlaserJK, PreacherKJ, MacCallumRC, et al.: Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA, 2003; 100:9090–9095.
33.
CohenS, DoyleWJ, SkonerDP: Psychological stress, cytokine production, and severity of upper respiratory illness. Psychosom Med, 1999; 61:175–180.
34.
LangrishCL, ChenY, BlumenscheinWM, et al.: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med, 2005; 201:233–240.
35.
IvanovII, McKenzieBS, ZhouL, et al.: The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell, 2006; 126:1121–1133.
36.
NishiharaM, OguraH, UedaN, et al.: IL-6–gp130–STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Int Immunol, 2007; 19:695–702.
37.
MooreKW, de Waal MalefytR, CoffmanRL, O'GarraA: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol, 2001; 19:683–765.
38.
AhmadSF, ZoheirKM, AnsariMA, et al.: Histamine 4 receptor promotes expression of costimulatory B7.1/B7.2 molecules, CD28 signaling and cytokine production in stress-induced immune responses. J Neuroimmunol, 2015; 289:30–42.
39.
TabarkiewiczJ, PogodaK, KarczmarczykA, PozarowskiP, GiannopoulosK: The role of IL-17 and Th17 lymphocytes in autoimmune diseases. Arch Immunol Ther Exp, 2015; 63:435–449.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
